Carisma Therapeutics Inc
:SESN 10:26:23 AM EDT
Products, Strategic Combinations
Sesen Bio Announces Commercial Manufacturing And Global Supply Partnership With Qilu
Published: 12/07/2020 13:19 GMT
(SESN) - Sesen Bio Announces Commercial Manufacturing and Global Supply Partnership With Qilu Pharmaceutical.
Sesen Bio Inc - Technology Transfer to Qilu Anticipated to Be Completed in Mid-2021.
Sesen Bio Inc - to Receive $2 Million Milestone Payment Upon Completion of Technology Transfer.
Sesen Bio Inc - Qilu Will Be Part of Contract Manufacturing Network for Global Commercial Supply of Vicineum in Agreement.
Sesen Bio Inc - on Track to Complete Bla for Vicineum and Submit to FDA Later This Month.
Sesen Bio Inc - Technology Transfer to Qilu Anticipated to Be Completed in Mid-2021.
Sesen Bio Inc - to Receive $2 Million Milestone Payment Upon Completion of Technology Transfer.
Sesen Bio Inc - Qilu Will Be Part of Contract Manufacturing Network for Global Commercial Supply of Vicineum in Agreement.
Sesen Bio Inc - on Track to Complete Bla for Vicineum and Submit to FDA Later This Month.